These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 17826748)
1. Structure-guided drug design: conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes. Taylor P; Talley TT; Radic' Z; Hansen SB; Hibbs RE; Shi J Biochem Pharmacol; 2007 Oct; 74(8):1164-71. PubMed ID: 17826748 [TBL] [Abstract][Full Text] [Related]
2. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors. Hansen SB; Taylor P J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates. Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805 [TBL] [Abstract][Full Text] [Related]
4. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors. Tsetlin V; Utkin Y; Kasheverov I Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053 [TBL] [Abstract][Full Text] [Related]
5. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors. Akdemir A; Rucktooa P; Jongejan A; Elk Rv; Bertrand S; Sixma TK; Bertrand D; Smit AB; Leurs R; de Graaf C; de Esch IJ Bioorg Med Chem; 2011 Oct; 19(20):6107-19. PubMed ID: 21920761 [TBL] [Abstract][Full Text] [Related]
6. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Taylor P; Bourne Y EMBO J; 2005 Oct; 24(20):3635-46. PubMed ID: 16193063 [TBL] [Abstract][Full Text] [Related]
7. Lessons from nature: Structural studies and drug design driven by a homologous surrogate from invertebrates, AChBP. Camacho-Hernandez GA; Taylor P Neuropharmacology; 2020 Nov; 179():108108. PubMed ID: 32353365 [TBL] [Abstract][Full Text] [Related]
8. Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism. Bourne Y; Radic Z; Aráoz R; Talley TT; Benoit E; Servent D; Taylor P; Molgó J; Marchot P Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6076-81. PubMed ID: 20224036 [TBL] [Abstract][Full Text] [Related]
9. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor. Xiao Y; Hammond PS; Mazurov AA; Yohannes D J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444 [TBL] [Abstract][Full Text] [Related]
10. Generation of candidate ligands for nicotinic acetylcholine receptors via in situ click chemistry with a soluble acetylcholine binding protein template. Grimster NP; Stump B; Fotsing JR; Weide T; Talley TT; Yamauchi JG; Nemecz Á; Kim C; Ho KY; Sharpless KB; Taylor P; Fokin VV J Am Chem Soc; 2012 Apr; 134(15):6732-40. PubMed ID: 22394239 [TBL] [Abstract][Full Text] [Related]
11. Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors. Molgó J; Aráoz R; Benoit E; Iorga BI Expert Opin Drug Discov; 2013 Oct; 8(10):1203-23. PubMed ID: 23919818 [TBL] [Abstract][Full Text] [Related]
12. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. Holladay MW; Dart MJ; Lynch JK J Med Chem; 1997 Dec; 40(26):4169-94. PubMed ID: 9435889 [No Abstract] [Full Text] [Related]
13. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors. Arias HR; Bhumireddy P; Bouzat C Int J Biochem Cell Biol; 2006; 38(8):1254-76. PubMed ID: 16520081 [TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of human pentameric alpha(7) neuronal nicotinic acetylcholine receptor and its interaction with its agonist and competitive antagonist. Parthiban M; Rajasekaran MB; Ramakumar S; Shanmughavel P J Biomol Struct Dyn; 2009 Apr; 26(5):535-47. PubMed ID: 19236104 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholine-Binding Protein Engineered to Mimic the α4-α4 Binding Pocket in α4β2 Nicotinic Acetylcholine Receptors Reveals Interface Specific Interactions Important for Binding and Activity. Shahsavar A; Ahring PK; Olsen JA; Krintel C; Kastrup JS; Balle T; Gajhede M Mol Pharmacol; 2015 Oct; 88(4):697-707. PubMed ID: 26180047 [TBL] [Abstract][Full Text] [Related]
16. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor. Brejc K; van Dijk WJ; Smit AB; Sixma TK Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010 [TBL] [Abstract][Full Text] [Related]
18. Discrimination of agonists versus antagonists of nicotinic ligands based on docking onto AChBP structures. Taly A; Colas C; Malliavin T; Blondel A; Nilges M; Corringer PJ; Joseph D J Mol Graph Model; 2011 Sep; 30():100-9. PubMed ID: 21764343 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes. Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]